Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etidronate vs alfacalcidol for vertebral fracture prevention in Japanese osteoporosis patients
jRCT1080220091Phase 4
- Sponsor
- Sumitomo Pharma
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of etidronate in involutional osteoporosis (2 arms), sponsored by Sumitomo Pharma. Primary endpoint: Incidence of vertebral fractures.
02
Drugs
etidronate
03
Conditions
involutional osteoporosis
Beyond the preview
Go deeper on jRCT1080220091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080220091.